Immunotherapy Deriving from CAR-T Cell Treatment in Autoimmune Diseases
Chimeric antigen receptor T (CAR-T) cells are T cells engineered to express specific synthetic antigen receptors that can recognize antigens expressed by tumor cells, which after the binding of these antigens to the receptors are eliminated, and have been adopted to treat several kinds of malignanci...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2019/5727516 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!